Key result
ARH deficiency in mice preserved LDLR-dependent clearance of VLDL remnants, with a VLDL half-life of 70 minutes compared to 362 minutes in LDLR-deficient mice.
Why the study?
Does ARH deficiency preserve VLDL clearance and attenuate hypercholesterolemia compared to LDLR deficiency in murine models?
Does ARH deficiency preserve VLDL clearance and attenuate hypercholesterolemia compared to LDLR deficiency in murine models?
The preservation of VLDL remnant clearance in ARH-deficient mice explains their milder hypercholesterolemic phenotype compared to LDLR-deficient mice and suggests why ARH patients respond better to statins.
Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr(-/-)) and ARH (Arh(-/-)). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh(-/-) mice compared with Ldlr(-/-) mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh(-/-) mice than in Ldlr(-/-) mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh(-/-) mice (but not Ldlr(-/-) mice) internalized beta-migrating VLDL (beta-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2007) studied Autosomal recessive hypercholesterolemia. ARH deficiency (Arh-/-) vs. LDLR deficiency (Ldlr-/-) and wild-type was evaluated on Half-life of 125I-labeled mouse VLDL (p=<0.01). ARH deficiency in mice preserved LDLR-dependent clearance of VLDL remnants, with a VLDL half-life of 70 minutes compared to 362 minutes in LDLR-deficient mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: